Clinical Trial Update: Phase I/II Trial of Everolimus in Combination With Lonafarnib in Progeria [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II trial evaluating the combination of Everolimus and Lonafarnib for Progeria is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progeria

Drugs mentioned

• Afinitor (everolimus)
• Zokinvy (Lonafarnib)

Snippet

Sponsor: Boston Children's Hospital | Conditions: Progeria | Phase 1, Phase 2 | Status: ENROLLING_BY_INVITATION